Phase II Trial Evaluating the Addition of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2018
Price : $35 *
At a glance
- Drugs Lucanthone (Primary)
- Indications Brain metastases
- Focus Therapeutic Use
- 30 Jan 2018 Planned End Date changed from 1 Jan 2018 to 29 Nov 2017.
- 30 Jan 2018 Planned primary completion date changed from 1 Jan 2018 to 29 Nov 2017.
- 30 Jan 2018 Status changed from suspended to withdrawn prior to enrolment.